Stoke Therapeutics Inc (STOK)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current STOK market cap is 825.06M. The company's latest EPS is USD -2.0088 and P/E is -7.88.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.15M | -2.48M | 3.31M | 2.8M | 4.22M |
| Operating Income | -24.69M | -33.26M | -27.23M | -29.59M | -28.37M |
| Net Income | -22.55M | -30.65M | -24.54M | -26.96M | -26.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 12.41M | 8.78M |
| Operating Income | -35.68M | -53.04M | -86.07M | -104.36M | -114.77M |
| Net Income | -32.33M | -52.24M | -85.81M | -101.07M | -104.7M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 281.8M | 256.92M | 239.89M | 228.34M | 205.18M |
| Total Liabilities | 67.97M | 66.72M | 66.89M | 68.78M | 64.84M |
| Total Equity | 213.82M | 190.2M | 173M | 159.57M | 140.34M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 228.75M | 297.93M | 238.87M | 256.07M | 228.34M |
| Total Liabilities | 4.32M | 11.85M | 21.09M | 71.22M | 68.78M |
| Total Equity | 224.43M | 286.08M | 217.78M | 184.85M | 159.57M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -21.36M | -43.16M | -60.42M | -81.07M | -24.57M |
| Investing | 53.09M | 76.56M | 91.18M | 105.95M | 9.99M |
| Financing | 45.05M | 45.1M | 45.66M | 53.01M | 1.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -31.06M | -42.22M | -66.91M | -31.87M | -81.07M |
| Investing | -1.63M | -1.05M | -76.43M | -45.88M | 105.95M |
| Financing | 149.76M | 108.11M | 1.28M | 46.41M | 53.01M |
| Market Cap | 825.06M |
| Price to Earnings Ratio | -7.88 |
| Price to Sales Ratio | 93.95 |
| Price to Cash Ratio | 4.31 |
| Price to Book Ratio | 5.17 |
| Dividend Yield | - |
| Shares Outstanding | 52.12M |
| Average Volume (1 week) | 544.62k |
| Average Volume (1 Month) | 673.12k |
| 52 Week Change | 150.47% |
| 52 Week High | 17.58 |
| 52 Week Low | 3.35 |
| Spread (Intraday) | 0.38 (2.38%) |
| Company Name | Stoke Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.stoketherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
